rxstat › Shortages › Timolol
Timolol shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Timolol is in a widespread shortage in Canada. 6 of 12 reported products are affected. The latest manufacturer estimate for full recovery is Jul 30, 2027.
In shortage since
Apr 15, 2016
Est. full return
Jul 30, 2027
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageSANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · since Jun 29, 2026, est. end Jul 10, 2026 · Delay in shipping of the drug.
Active shortageAPO-TIMOP
0.5% · SOLUTION · APOTEX INC
DIN 00755834 · since Jan 14, 2025, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortageTIMOLOL MALEATE-EX
0.5% · SOLUTION (EXTENDED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02242276 · since Nov 17, 2025, est. end Jul 30, 2027 · Disruption of the manufacture of the drug.
Active shortageTIMOLOL MALEATE-EX
0.25% · SOLUTION (EXTENDED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02242275 · since May 13, 2024, est. end Jul 30, 2027 · Disruption of the manufacture of the drug.
Active shortageODAN-TIMOLOL
0.5% · LIQUID · ODAN LABORATORIES LTD
DIN 02010240 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortageODAN-TIMOLOL
0.25% · LIQUID · ODAN LABORATORIES LTD
DIN 02010259 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
ResolvedJAMP-TIMOLOL
0.5% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02447800 · ended Jun 1, 2026 · Demand increase for the drug.
ResolvedSANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ TIMOLOL
0.25% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166712 · ended Dec 3, 2025 · Demand increase for the drug.
ResolvedTIMOPTIC
0.5% · SOLUTION · ELVIUM LIFE SCIENCES
DIN 00451207 · ended Dec 12, 2025 · Demand increase for the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Timolol is currently affected by 6 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, APOTEX INC, ODAN LABORATORIES LTD.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Timolol is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01ED).
Recent changes
Common questions
When will Timolol be back in stock in Canada?
The latest manufacturer estimate is Jul 30, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Timolol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antiglaucoma preparations and miotics shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.